Your browser is no longer supported. Please, upgrade your browser.
BSGM BioSig Technologies, Inc. daily Stock Chart
BioSig Technologies, Inc.
Index- P/E- EPS (ttm)-1.76 Insider Own8.70% Shs Outstand24.39M Perf Week-2.83%
Market Cap206.78M Forward P/E38.92 EPS next Y0.19 Insider Trans1.45% Shs Float22.61M Perf Month-28.00%
Income-39.50M PEG- EPS next Q-0.39 Inst Own13.30% Short Float12.53% Perf Quarter39.26%
Sales- P/S- EPS this Y-12.00% Inst Trans0.50% Short Ratio3.08 Perf Half Y22.87%
Book/sh0.62 P/B11.61 EPS next Y112.20% ROA-271.10% Target Price- Perf Year-19.46%
Cash/sh0.54 P/C13.34 EPS next 5Y- ROE-327.00% 52W Range2.36 - 12.43 Perf YTD21.62%
Dividend- P/FCF- EPS past 5Y6.20% ROI- 52W High-42.08% Beta1.43
Dividend %- Quick Ratio9.90 Sales past 5Y- Gross Margin- 52W Low205.08% ATR0.78
Employees33 Current Ratio10.50 Sales Q/Q- Oper. Margin- RSI (14)33.49 Volatility6.40% 8.65%
OptionableYes Debt/Eq0.00 EPS Q/Q-41.10% Profit Margin- Rel Volume0.69 Prev Close7.11
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume918.73K Price7.20
Recom2.00 SMA20-16.29% SMA50-24.73% SMA2007.31% Volume635,241 Change1.27%
Mar-30-20Initiated ROTH Capital Buy $9
Jul-10-20 01:15PM  
Jul-01-20 09:15AM  
Jun-29-20 08:18AM  
Jun-24-20 09:20AM  
Jun-22-20 02:30PM  
Jun-17-20 07:55AM  
Jun-08-20 03:02PM  
Jun-05-20 09:10AM  
Jun-04-20 09:25AM  
Jun-03-20 11:45AM  
Jun-01-20 10:42AM  
May-28-20 08:40AM  
May-20-20 10:12AM  
May-18-20 08:32AM  
May-14-20 08:15AM  
May-07-20 03:17PM  
May-05-20 02:10PM  
May-01-20 10:39AM  
Apr-30-20 09:20AM  
Apr-24-20 02:30PM  
Apr-23-20 09:15AM  
Apr-21-20 02:36PM  
Apr-17-20 02:07PM  
Apr-16-20 09:45AM  
Apr-09-20 08:22AM  
Apr-03-20 01:10PM  
Mar-31-20 08:45AM  
Mar-25-20 07:52AM  
Mar-22-20 08:31AM  
Mar-10-20 08:05AM  
Mar-04-20 07:52AM  
Mar-03-20 12:20PM  
Feb-26-20 08:33AM  
Feb-25-20 03:25PM  
Feb-21-20 08:45AM  
Feb-20-20 04:18PM  
Feb-19-20 08:33AM  
Jan-21-20 07:52AM  
Jan-16-20 07:52AM  
Jan-14-20 07:52AM  
Dec-23-19 05:57AM  
Dec-03-19 07:52AM  
Dec-02-19 03:40PM  
Nov-26-19 07:52AM  
Nov-21-19 07:52AM  
Nov-18-19 07:52AM  
Nov-14-19 07:52AM  
Nov-07-19 07:52AM  
Nov-06-19 07:52AM  
Oct-29-19 07:52AM  
Oct-24-19 11:02AM  
Oct-15-19 07:52AM  
Oct-10-19 07:52AM  
Sep-30-19 07:52AM  
Sep-26-19 07:52AM  
Sep-16-19 08:09AM  
Sep-12-19 07:52AM  
Sep-09-19 01:06PM  
Sep-05-19 07:52AM  
Aug-01-19 09:00AM  
Jul-24-19 07:52AM  
Jul-18-19 07:52AM  
Jul-15-19 10:45AM  
Jul-11-19 07:52AM  
Jul-01-19 07:52AM  
Jun-25-19 07:52AM  
Jun-20-19 07:52AM  
Jun-10-19 09:17AM  
Jun-06-19 07:52AM  
Jun-03-19 07:52AM  
May-30-19 07:52AM  
May-23-19 07:52AM  
May-21-19 07:52AM  
May-20-19 07:52AM  
May-06-19 07:52AM  
May-02-19 07:52AM  
Apr-30-19 07:52AM  
Apr-16-19 07:52AM  
Apr-09-19 07:52AM  
Mar-26-19 07:52AM  
Mar-14-19 09:18AM  
Mar-12-19 08:45AM  
Mar-08-19 07:52AM  
Mar-07-19 07:52AM  
Mar-06-19 07:52AM  
Feb-26-19 07:52AM  
Feb-21-19 08:00AM  
Feb-20-19 07:52AM  
Feb-12-19 07:52AM  
Feb-05-19 07:52AM  
Jan-31-19 10:23AM  
Dec-19-18 08:00AM  
Dec-10-18 06:51AM  
BioSig Technologies, Inc., a medical technology company, engages in developing a proprietary biomedical signal processing platform designed to improve the electrophysiology (EP) marketplace. The company's first product, PURE EPTM System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory. The system is indicated for use under the supervision of licensed healthcare practitioners who are responsible for interpreting the data. This novel cardiac signal acquisition and display system is engineered to assist electrophysiologists in clinical decision-making during electrophysiology procedures in patients with abnormal heart rates and rhythms. The company has partnered with Minnetronix on technology development and received FDA 510(k) clearance for the PURE EPTM System in August 2018. It is also developing a library of software tools that are designed to be configured to fit the needs of electrophysiologists in various settings and for arrhythmia treatments. The company has partnership with Albany Molecular Research Inc. for support in undertaking research to investigate the potential of merimepodib to fight SARS-CoV-2, the virus that causes COVID-19 as a standalone treatment or in combination with other anti-viral agents or immune modulators. BioSig Technologies, Inc. was founded in 2009 and is headquartered in Westport, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LONDONER KENNETH LChief Executive OfficerMay 29Buy9.264,00037,0201,282,758May 29 11:30 AM
ZELDIS JEROME BDirectorMay 28Buy10.491,00010,489107,944May 28 10:58 AM
LONDONER KENNETH LChief Executive OfficerMay 26Buy10.843,60039,0141,278,758May 26 10:57 AM
Pease MarthaDirectorMar 23Buy3.003,0009,0009,437Mar 25 02:55 PM
CHAUSSY STEVEChief Financial OfficerMar 19Buy3.051,8665,697679,128Mar 19 02:30 PM
Kowalski John MVP of SalesMar 19Buy2.983,0008,940112,000Mar 19 02:16 PM
Kowalski John MVP of SalesMar 17Buy2.711,0002,710109,000Mar 17 12:16 PM
CHAUSSY STEVEChief Financial OfficerMar 16Buy2.614,00010,440677,262Mar 16 01:35 PM
LONDONER KENNETH LChief Executive OfficerMar 16Buy2.768,80024,2881,270,791Mar 16 11:25 AM
Kowalski John MVP of SalesMar 16Buy2.921,0002,920108,000Mar 17 12:16 PM
LONDONER KENNETH LChief Executive OfficerMar 16Buy2.704,36711,7861,275,158Mar 16 02:22 PM
LONDONER KENNETH LChief Executive OfficerJan 16Option Exercise5.23100,000523,0001,358,393Jan 21 08:14 PM
CHAUSSY STEVEChief Financial OfficerJan 16Option Exercise5.2312,00062,760684,830Jan 21 08:08 PM
ODONNELL JEFFREY FDirectorDec 18Option Exercise5.2338,320200,414257,695Dec 20 09:56 PM
Pease MarthaDirectorNov 22Buy6.251,3008,1256,437Nov 26 09:48 AM
Pease MarthaDirectorNov 21Buy6.201,0006,2005,137Nov 22 05:38 PM
Pease MarthaDirectorNov 20Buy6.201,0006,2004,137Nov 22 05:38 PM
Pease MarthaDirectorNov 19Buy6.251,0006,2503,137Nov 22 05:38 PM
NAVARRO SAMUEL EDirectorNov 18Buy6.461,0006,4603,500Nov 19 05:18 PM
Pease MarthaDirectorNov 18Buy6.551,0006,5502,137Nov 19 05:14 PM
Pease MarthaDirectorNov 15Buy6.811,0006,8101,000Nov 15 07:26 PM
Pease MarthaDirectorNov 15Buy6.651379111,137Nov 19 05:14 PM